Glenmark introduces 3-in-1 inhaler therapy for COPD, promising reduction in risk of severe attacks and improvement in lung function
AIRZ-FF is India’s first Glycopyrronium + Formoterol + Fluticasone combination, exclusively studied in the Indian population
Backed by latest research which shows significant Glenmark introduces 3 bronchodilation, with reductionin riskof severe attacks andreduced need for multiple inhalers
Expected to benefit 12.8million Indian patients suffering with severe form ofCOPD, and thereby addressing the country’s high disease burden
In line with Glenmark’s novel additions to respiratory medicine – from introducing the world’s first digital inhaler to launching India’s first glycopyrronium as dry powder for inhalation and as solution for nebulization.
May 2020: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced the launch of a Single Inhaler Triple Glenmark introduces 3 Therapy AIRZ-FF – a combination of two bronchodilators, Glycopyrronium & Formoterol and the inhalation corticosteroid Fluticasone propionate, for Chronic Obstructive Pulmonary Disease (COPD).
This new triple therapy innovation comes with multiple benefits: it offers significant bronchodilation (making breathing easier), reduces risk of severe attacks, and eliminates dependence on multiple inhalers.1The reduction in risk of severe attacks decreases the requirement for hospitalization, a benefit of high significance in current prevailing situation.1
AIRZ-FF has been exclusively studied in the Indian population1 and introduced to address challenges faced by a significant portion of COPD patients in the country. COPD is a very common, serious and debilitating lung disease which like hypertension or diabetes, requires personalized treatment over the rest of the patient’s life.
India is currently home to more than 55.3 million people living with COPD of varying degrees of severity. The disease prevalence has grown significantly by 24% in the last decade alone. Health experts attribute this rise tolow levels of awareness and low rates of diagnosis of the disease. Together these factors have made COPD the second leading cause of death by disease in India.1,2,3
“COPD poses a significant public health challenge in India for many reasons. When it comes to treatment, there is poor patient compliance and adherence to prescribed doses, owing to the need for multiple inhalers through the day. By introducing AIRZ-FF, we hope to reduce this burden for patients, by delivering three effective therapies together in the same inhaler,” said Sujesh Vasudevan, President, India Formulations, Middle East and Africa at Glenmark Pharmaceuticals.He added, “Glenmark continues to invent and innovate healthcare solutions that meet specific and often hard-to-address needs of patients in India and the world.”
Of the global COPD burden, about 35% is attributed to tobacco smoking. The remaining 65% is seen in non-smokers, mostly living in low and middle income countries. In India, a substantial number of COPD cases occur in people who have never smoked. They has beenascribedto ambient air pollution, occupational exposure to dust and gases, poor living conditions, repeated respiratory tract infections and exposure to indoor biomass smoke5.
According to global organizations on respiratory medicine, patients most likely to benefit from triple therapy, include those with history of multiple or severe attacks, despite appropriate use of singular or dual bronchodilators alone.
Empower your team. Lead the industry
Get a subscription to a library of online courses and digital learning tools for your organization with EasyShiksha
Yes, all internships offered by EasyShiksha are completely free of charge.
Q.How can I apply for an internship with EasyShiksha?
You can apply for an internship with EasyShiksha by visiting our website and browsing through the available internship opportunities. Once you find a suitable internship, simply follow the application instructions provided.
Q.What types of internships are available through EasyShiksha?
EasyShiksha offers a wide range of internships across various industries and disciplines, including but not limited to technology, business, marketing, healthcare, and more. We continuously update our internship offerings to provide diverse opportunities for our users.
Q.Will I receive a certificate upon completing an internship?
Yes, upon successful completion of an internship with EasyShiksha, you will receive a certificate recognizing your participation and achievements during the internship period.
Q.Are EasyShiksha's internship certificates recognized by universities and employers?
Yes, EasyShiksha's internship certificates are recognized and valued by universities, colleges, and employers worldwide. They serve as a testament to your skills, knowledge, and experience gained through our internship programs.
Q.Is the download of certificates free or paid?
While access to internships and all courses on EasyShiksha is free for users lifetime, there is a nominal operational cost associated with downloading certificates. This fee covers the administrative expenses involved in processing and issuing the certificates.
Q.When can I start the course?
Anyone can choose a preferred course and start immediately without any delay.
Q.What are the course and session timings?
As this is a purely online course program, you can choose to learn at any time of the day and for as much time as you want. Though we follow a well-established structure and schedule, we recommend a routine for you as well. But it finally depends on you, as you have to learn.
Q.What will happen when my course is over?
If you have completed the course, you would be able to have lifetime access to it for future reference too.
Q.Can I download the notes and study material?
Yes, you can access and download the content of the course for the duration. And even have lifetime access to it for any further reference.
Q. What software/tools would be needed for the course and how can I get them?
All the software/tools that you need for the course would be shared with you during the training as and when you need them.
I’m unable to make a payment. What to do now?
You can try to make the payment through a different card or account (maybe a friend or family). If the problem persists, email us at info@easyshiksha.com
Q. Do I get the certificate in a hard copy?
No, only a soft copy of the certificate will be awarded, which can be downloaded and printed, if required.
Q. The payment got deducted, but the updated transaction status is showing “failed”. What to do now?
Due to some technical faults, this can happen. In such a case the amount deducted will be transferred to the bank account in the next 7-10 working days. Normally the bank takes this much time to credit the amount back into your account.
Q. The payment was successful but it still shows ‘Buy Now’ or not showing any videos on my dashboard? What should I do?
At times, there may be a slight delay in your payment reflecting on your EasyShiksha dashboard. However, if the problem is taking longer than 30 minutes, please let us know by writing to us at info@easyshiksha.com from your registered email id, and attach the screenshot of the payment receipt or transaction history. Soon after verification from the backend, we will update the payment status.
Q. What is the refund policy?
If you have enrolled, and are facing any technical problem then you can request a refund. But once the certificate has been generated, we shall not refund that..
Q.Can I just enrol in a single course?
Yes! You surely can. To begin this, just click the course of your interest and fill in the details to enrol. You are ready to learn, once the payment is made. For the same, you earn a certificate too.
My questions are not listed above. I need further help.
